Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic adipose derived mesenchymal stem cell (2 trials)
autologous endothelial progenitor cells (1 trial)
autologous mesenchymal stem cells (1 trial)
autologous umbilical cord blood (1 trial)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Infarction (Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Stroke (Phase 2)
Trials (3 total)
Trial APIs (4 total)